Klass Russell Kevin 4
4 · Zomedica Corp. · Filed Jun 12, 2024
Insider Transaction Report
Form 4
Klass Russell Kevin
Sr Vice President, Sales
Transactions
- Purchase
Common Stock, without par value
2024-06-11$0.15/sh+500,000$75,100→ 1,700,057 total - Purchase
Common Stock, without par value
2024-06-10$0.15/sh+200,007$29,941→ 1,200,057 total
Footnotes (2)
- [F1]The price reported is the weighted average price. These shares were sold in multiple transactions ranging from $0.1495 to $0.1499, inclusive. The reporting person undertakes to provide to Zomedica Corp., any security holder of Zomedica Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence.
- [F2]The price reported is the weighted average price. These shares were sold in multiple transactions ranging from $0.1485 to $0.1526, inclusive. The reporting person undertakes to provide to Zomedica Corp., any security holder of Zomedica Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence.